National Library of New Zealand
Harvested by the National Library of New Zealand on: Nov 9 2016 at 16:08:13 GMT
Search boxes and external links may not function. Having trouble viewing this page? Click here
Close Minimize Help
Wayback Machine
GayNZ Logo & Link
Thursday 10 November 2016


HIV antibody trial has a breakthrough

Posted in: International News, HIV
By GayNZ.com Daily News staff - 9th April 2015

generic_2.jpg
A new HIV treatment using a synthetic antibody has led to a 300-fold reduction in patients’ viral loads in trials.

The antibody is designed to prevent the virus from attacking human cells.

The dramatic lowering of the viral load lasted for a number of weeks after the injection for some patients.

Researchers believe synthetic antibodies could not only provide an alternative form of treatment to anti-retroviral drugs, but may also help to design therapeutic vaccines.

They could also potentially be used in combination with existing anti-retroviral drugs to maintain better control over the infection.

"One antibody alone, like one drug alone, will not be sufficient to suppress viral load for a long time because resistance will arise," said Marina Caskey of the Rockefeller University in New York, the lead author of the study published in the journal Nature, has told The Independent.

"What's special about these antibodies is that they have activity against over 80 per cent of HIV strains and they are extremely potent.”

You can find the full study here


 
   Bookmark and Share




 Latest News Headlines

Trump's VP has history of anti-glbti views
Corrections recommends Letele for early release
Westie Lesbian Ball is cancelled, no promise for '17
Corrections consider advocating for dying prisoner
UN expert on LGBTI rights may lose his job